Artificial intelligence-driven therapeutics for disease modification in type 1 diabetes: a digital public health and clinical translation framework

Type 1 diabetes (T1D) is a chronic autoimmune disorder characterized by immune-mediated destruction of pancreatic β-cells, resulting in absolute insulin deficiency and lifelong dependence on exogenous insulin therapy.